BPMC

Blueprint Medicines
BPMC

Overview Fund Activity
Delisted

BPMC was delisted on the 17th of July, 2025.

Back to rankings

347 hedge funds and large institutions have $8.2B invested in Blueprint Medicines in 2025 Q2 according to their latest regulatory filings, with 107 funds opening new positions, 94 increasing their positions, 115 reducing their positions, and 105 closing their positions.

Holders
347
Holders Change
-2
Holders Change %
-0.57%
% of All Funds
4.66%
Holding in Top 10
29
Holding in Top 10 Change
+20
Holding in Top 10 Change %
+222.22%
% of All Funds
0.39%
New
107
Increased
94
Reduced
115
Closed
105
Calls
$131M
Puts
$151M
Net Calls
-$20M
Net Calls Change
-$63.9M

Top Buyers

1
PCM
1
Pentwater Capital Management
Florida
$500M
2
UBS Group
2
UBS Group
Switzerland
$278M
3
Fidelity International
3
Fidelity International
Bermuda
$226M
4
UOC
4
UBS O'Connor
Illinois
$220M
5
Barclays
5
Barclays
United Kingdom
$200M

Top Sellers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$188M
2
ACA
2
Avoro Capital Advisors
New York
$48.1M
3
Wellington Management Group
3
Wellington Management Group
Massachusetts
$55.9M
4
JPMorgan Chase & Co
4
JPMorgan Chase & Co
New York
$53.6M
5
William Blair Investment Management
5
William Blair Investment Management
Illinois
$1.1M
Name Market Value Shares Shares
Change 		Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$822M 6,416,603 -223,920 -3%
BlackRock
2
BlackRock
New York
$784M 6,118,428 -592,280 -9%
PCM
3
Pentwater Capital Management
Florida
$500M 3,900,000 +3,900,000 New
State Street
4
State Street
Massachusetts
$286M 2,230,980 -453,137 -17%
UBS Group
5
UBS Group
Switzerland
$278M 2,167,028 +1,953,223 +914%
Fidelity International
6
Fidelity International
Bermuda
$226M 1,759,500 +1,759,500 New
UOC
7
UBS O'Connor
Illinois
$220M 1,713,587 +1,698,722 +11,428%
Barclays
8
Barclays
United Kingdom
$200M 1,556,918 +1,427,323 +1,101%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$198M 1,541,013 +18,366 +1%
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$188M 1,464,968 -3,950,869 -73%
GCL
11
Glazer Capital LLC
New York
$171M 1,331,300 +1,331,300 New
Norges Bank
12
Norges Bank
Norway
$138M 1,074,936 +1,074,936 New
BCM
13
Beryl Capital Management
California
$137M 1,067,224 +1,067,224 New
AAM
14
Alpine Associates Management
Florida
$136M 1,060,307 +1,060,307 New
DKCM
15
Davidson Kempner Capital Management
New York
$133M 1,035,100 +1,035,100 New
Morgan Stanley
16
Morgan Stanley
New York
$132M 1,031,170 +462,471 +81%
Macquarie Group
17
Macquarie Group
Australia
$118M 922,167 -364,730 -28%
Goldman Sachs
18
Goldman Sachs
New York
$114M 891,287 -35,381 -4%
SCS
19
Syquant Capital SAS
France
$103M 805,603 +805,603 New
AllianceBernstein
20
AllianceBernstein
Tennessee
$98.1M 765,387 -430,853 -36%
MF
21
Magnetar Financial
Illinois
$93.6M 730,047 +725,479 +15,882%
EAM
22
Eventide Asset Management
Massachusetts
$93.4M 728,821 -133,728 -16%
Renaissance Technologies
23
Renaissance Technologies
New York
$86.5M 674,500 +674,500 New
Bank of America
24
Bank of America
North Carolina
$83M 647,487 -69,419 -10%
Northern Trust
25
Northern Trust
Illinois
$72.9M 568,924 -20,635 -4%
1
2 3 4 5